Extract from the Register of European Patents

EP About this file: EP4088727

EP4088727 - ANTI-GLYCATION COMPOSITIONS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  13.03.2026
Database last updated on 18.03.2026
FormerRequest for examination was made
Status updated on  19.05.2023
FormerThe application has been published
Status updated on  14.10.2022
Most recent event   Tooltip13.03.2026Application deemed to be withdrawnpublished on 15.04.2026 [2026/16]
Applicant(s)For all designated states
AHAVA - DEAD SEA LABORATORIES LTD.
1 Arava St.
P.O.B. 109
7015002 Lod / IL
[2022/46]
Inventor(s)01 / Cohen, Dror
8698000 D.N the Dead Sea / IL
02 / Portugal Cohen, Meital
9641210 Jerusalem / IL
03 / Blinderman, Alexandra
9066500 M.P. Arvot Ha Yarden / IL
04 / Barak, David
7177709 Modi'in / IL
05 / Ze'evi, Ma'or
9066600 Dead Sea D.N Arvot Hayarden / IL
 [2022/46]
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstraße 3
81675 München / DE
[2022/46]
Application number, filing date21176839.531.05.2021
[2022/46]
Priority number, dateUS20211731944613.05.2021         Original published format: US202117319446
[2022/46]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP4088727
Date:16.11.2022
Language:EN
[2022/46]
Search report(s)(Supplementary) European search report - dispatched on:EP29.11.2021
ClassificationIPC:A61K33/00, A61K36/28, A61K36/77, A61P17/00
[2022/46]
CPC:
A61P17/00 (EP,CN,IL); A61K35/08 (IL,US); A61K8/9789 (CN,IL,US);
A61K33/00 (EP,IL); A61K33/06 (EP,IL); A61K33/22 (EP,IL);
A61K33/24 (EP,IL); A61K35/02 (CN); A61K36/28 (EP,CN,IL,US);
A61K36/324 (EP,IL); A61K36/328 (CN,IL,US); A61K36/725 (CN,IL,US);
A61K36/77 (EP,IL); A61K8/965 (CN,IL,US); A61P17/18 (CN);
A61Q19/00 (CN); A61Q19/08 (CN,IL,US); A61K2300/00 (IL) (-)
C-Set:
A61K33/00, A61K2300/00 (EP);
A61K33/06, A61K2300/00 (EP);
A61K33/22, A61K2300/00 (EP);
A61K33/24, A61K2300/00 (EP);
A61K35/02, A61K2300/00 (CN);
A61K36/28, A61K2300/00 (EP,CN);
A61K36/324, A61K2300/00 (EP);
A61K36/328, A61K2300/00 (CN);
A61K36/725, A61K2300/00 (CN);
A61K36/77, A61K2300/00 (EP)
(-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/25]
Former [2022/46]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
Extension statesBANot yet paid
MENot yet paid
Validation statesKHNot yet paid
MANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:ANTIGLYKIERUNGZUSAMMENSETZUNGEN[2022/46]
English:ANTI-GLYCATION COMPOSITIONS[2022/46]
French:COMPOSITIONS ANTI-GLYCATION[2022/46]
Examination procedure12.05.2023Amendment by applicant (claims and/or description)
12.05.2023Examination requested  [2023/25]
12.05.2023Date on which the examining division has become responsible
02.12.2025Application deemed to be withdrawn, date of legal effect  [2026/16]
17.12.2025Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2026/16]
Fees paidRenewal fee
21.03.2023Renewal fee patent year 03
13.03.2024Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
31.05.202505   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XY] RU2228771  
 [Y] EP2174648  (AHAVA DEAD SEA LAB LTD et al.)
 [Y] IL232044  
 [XY]   DATABASE WPI Week 200443, Derwent World Patents Index; AN 2004-459431, XP002804757
by applicantTWI469778
 US2013078202
 US6871805
 US10722461
 US2007203240
 US10512603
 RU2253433
 EP1074245
 US2006002929
 US2003049255
 EA033620
 US2003007939
 US6800292
 US2009093440
 WO02069963
 US2008044373
 US2020214955
 US10842733
 JP2002370963
 JP2002212046
 WO2015030702
 US9511034
 US8846019
 EP3398585
 US7435432
 US7666442
 US2011044920
   NARDA, M.PENO-MAZZARINO, L.KRUTMANN, J.TRULLAS, C.GRANGER, C.: "Novel Facial Cream Containing Carnosine Inhibits Formation of Advanced Glycation End-Products in Human Skin", SKIN PHARMACOLOGY AND PHYSIOLOGY, vol. 31, no. 6, 2018, pages 324 - 331
   SHIN, S.LEE, J.-A.KIM, M.KUM, H.JUNG, E.PARK, D.: "Anti-glycation activities of phenolic constituents from Silybum marianum (Milk Thistle) flower in vitro and on human explants", MOLECULES, vol. 20, no. 3, 2015, pages 3549 - 3564, XP055245503, DOI: 10.3390/molecules20033549

DOI:   http://dx.doi.org/10.3390/molecules20033549
   DAVE CHANDLER: "Effects of plant-derived polyphenols on TNF-alpha and nitric oxide production induced by advanced glycation end products", MOL. NUTR. FOOD RES., vol. 54, 2010, pages S141 - S150
   CHI-HAO WU: "Silymarin: a novel antioxidant with antiglycation and anti-inflammatory properties in vitro and in vivo", ANTIOXID. REDOX. SIGNAL., vol. 14, 2011, pages 353 - 366
   AHMED ALHUSBAN: "Silymarin Ameliorates Diabetes-Induced Proangiogenic Response in Brain Endothelial Cells through a GSK-3(3 Inhibition-Induced Reduction of VEGF Release", J. DIABETES RES., 25 October 2017 (2017-10-25), pages 2537216
   SAURABH AWASTHIAN. T. SARASWATHI.: "Silybin, a flavonolignan from milk thistle seeds, restrains the early and advanced glycation end product modification of albumin", RSC ADV, vol. 5, 2015, pages 87660 - 87666
   PORTUGAL-COHEN, M.COHEN, D.ISH-SHALOM, E.LAOR-COSTA, Y.MA'OR, Z. E.: "Dead Sea minerals: New findings on skin and the biology beyond", EXPERIMENTAL DERMATOLOGY, vol. 28, no. 5, 2019, pages 585 - 592
   JESSICA V. VALENCIA: "Advanced glycation end product ligands for the receptor for advanced glycation end products: biochemical characterization and formation kinetics", ANALYTICAL BIOCHEMISTRY, vol. 324, 2004, pages 68 - 78, XP004476319, DOI: 10.1016/j.ab.2003.09.013

DOI:   http://dx.doi.org/10.1016/j.ab.2003.09.013
   G.B. SAJITHLAL: "Advanced glycation end products induce crosslinking of collagen in vitro", BIOCHIMICA ET BIOPHYSICA ACTA, vol. 1407, 1998, pages 215 - 224, XP004276781, DOI: 10.1016/S0925-4439(98)00043-X

DOI:   http://dx.doi.org/10.1016/S0925-4439(98)00043-X
   HUANG, D.OU, B.HAMPSCH-WOODILL, M.FLANAGAN, J. A.PRIOR, R. L.: "High-throughput assay of oxygen radical absorbance capacity (ORAC) using a multichannel liquid handling system coupled with a microplate fluorescence reader in 96-well format", JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, vol. 50, no. 16, 2002, pages 443 - 4444
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.